Silicone Gel vs. Estrogen Vaginal Cream for the Management of Genitourinary Syndrome of Menopause
Eligible age
18+ yrs
Accepts
Women
Locations
3 states
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
The goal of this randomized controlled trial is to test the efficacy of StrataMGT in the management of Genitourinary Syndrome of Menopause (GSM) compared to estrogen therapy. The main question it aims to answer is: \- Will StrataMGT be non-inferior regarding patient quality of life compared to standard of care? Participants will use either StrataMGT or estrogen vaginal cream to treat GSM for 3 consecutive months. After the baseline assessment, participants will be assessed monthly for quality of life, clinical signs, symptoms, pathology and adverse reactions.
Sponsor: Stratpharma AG
You may qualify if…
- ✓ Able to provide informed consent
- ✓ Confirmed postmenopausal age
- ✓ Diagnosed genitourinary syndrome of menopause
- ✓ Access to a smartphone, tablet or computer, and to a functional email address.
You may not qualify if…
- ✕ Contraindication for the use of estrogen therapy
- ✕ Unable to provide informed consent
- ✕ Patient unable to apply topical device
- ✕ Allergy or intolerance to ingredients or excipients of the formulation of studied products
Where it's recruiting
Source: ClinicalTrials.gov · NCT05672901 · last updated 2026-02-20